title: Effects of melatonin on dopamine metabolism in the hypothalamus and the pituitary of the rainbow trout, Oncorhynchus mykiss.
abstract: The present paper discusses the effect of a single melatonin treatment (0.5 mg/kg, i.p.) on the dopaminergic metabolism in the hypothalamus and pituitary of the rainbow trout. The effects of exogenous melatonin on dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) contents were compared with the variations in the content of these catecholamines associated to the natural increase in the endogenous melatonin from daytime (3 hr before lights off) to nighttime (3 hr after lights off). Animals treated with melatonin showed a rapid (maximal values at 30 min post-injection) and relatively sustained rise in plasma melatonin levels, which reached supraphysiological ranges. The increase in circulating melatonin was accompanied by a reduction in the amount of DOPAC in both the hypothalamus (30, 60, and 120 min after i.p. melatonin) and the pituitary (120 min after i.p. melatonin) as well as in the pituitary DOPAC/DA ratio (60 and 120 min after i.p. melatonin). Similarly, the increase in circulating melatonin levels from the daytime to nighttime was associated with decreases in the contents of DOPAC in both the hypothalamus and pituitary and in the DOPAC/DA ratio in the pituitary. These data suggest that the inhibition of the hypothalamic-pituitary dopaminergic metabolism may be a specific mechanism of melatonin action in the trout brain that might operate following changes in the secretion of the hormone from the pineal gland.
authors.affiliation: Laboratorio de Fisioloxía Animal, Facultade de Bioloxía, Universidade de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Hernández-Rauda
authors.forename: J M
authors.initials: JM
authors.lastname: Miguez
authors.forename: C
authors.initials: C
authors.lastname: Ruibal
authors.forename: M
authors.initials: M
authors.lastname: Aldegunde
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D002940:Circadian Rhythm; D004298:Dopamine / Q000378:metabolism*; D007031:Hypothalamus / Q000187:drug effects* / Q000378:metabolism; D007274:Injections, Intraperitoneal; D008550:Melatonin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D017686:Oncorhynchus mykiss / Q000502:physiology*; D010902:Pituitary Gland / Q000187:drug effects* / Q000378:metabolism
chemical_list: D015102:3,4-Dihydroxyphenylacetic Acid; D008550:Melatonin; D004298:Dopamine